June 28, 2024 Hims & Hers shares plunge 12% amid allegations of GLP-1 drug sourcing from ‘shady supplier’ A new report criticized Hims GLP-1 offerings, specifically where the company is getting them from. BY Sam Becker Roughly a month after announcing that it would offer GLP-1 injectable weight-loss drugs comparable to the popular drugs Ozempic and … Continue reading Hims & Hers shares plunge 12% amid allegations of GLP-1 drug sourcing from ‘shady supplier’ →